Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Chugai

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Chugai's Japan sales performance.

Oncology drives AstraZeneca, Genzyme boosts Sanofi

Oncology drives AstraZeneca, Genzyme boosts Sanofi AZ confirmed it will continue to drive oncology advancements, citing its recent partnership with Japan-based pharma group Daiichi Sankyo.

Sobi shows strong growth despite haemophilia competition

Sobi shows strong growth despite haemophilia competition countries. Marketing rights to the drugs in the US, Canada and Japan are held by Bioverativ, which was acquired last year by Sanofi.

Novartis and Amgen come to blows over migraine partnership

Novartis and Amgen come to blows over migraine partnership US as well as commercial rights elsewhere with the exception of Japan.

Roivant forms Asian cell therapy ‘vant’, with Medigene’s help

Roivant forms Asian cell therapy ‘vant’, with Medigene’s help in Greater China, South Korea, and Japan.

AZ makes $6.9bn play for Daiichi Sankyo HER2 drug

AZ makes $6.9bn play for Daiichi Sankyo HER2 drug The companies will split the costs of bringing the ADC to market and share in global profits, with the exception of Japan where Daiichi Sankyo retains exclusive rights to what it

[ Previous 5 results ] 14 15 16 17 18 19 20 21 22 23 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics